Royal Bank of Canada’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Royal Bank of Canada’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,505	Closed	-$155K	–	6729
2014 Q4	$155K	Sell	4,505 -6,796	-60%	-$222K	﹤0.01%	4508
2014 Q3	$337K	Sell	11,301 -17,716	-61%	-$376K	﹤0.01%	3822
2014 Q2	$582K	Buy	29,017 +21,091	+266%	+$484K	﹤0.01%	3280
2014 Q1	$215K	Buy	7,926 +1,555	+24%	+$41.3K	﹤0.01%	4059
2013 Q4	$132K	Buy	6,371 +1,280	+25%	+$24.1K	﹤0.01%	4426
2013 Q3	$93K	Sell	5,091 -41,917	-89%	-$757K	﹤0.01%	4520
2013 Q2	$782K	Buy	+47,008	New	+$751K	﹤0.01%	2773

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Royal Bank of Canada's AUXL Position: Q1 2015 in Review

Royal Bank of Canada sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 4,505 shares — an estimated $155K sold.

Royal Bank of Canada first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $782K in Q2 2013. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Royal Bank of Canada reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Royal Bank of Canada sold 4,505 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $155K.
Royal Bank of Canada first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Royal Bank of Canada's AUXILIUM PHARAMCEUTICALS INC position peaked at $782K in Q2 2013.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Royal Bank of Canada's 13F filing for Q1 2015, filed 15 May 2015.